Identification of surface associated antigen FLJ31461 for tumor diagnosis and therapy
US10724103B2 · kind B2 · utility
Inventors
Key dates
| Filing date | Aug 11, 2017 |
| Grant date | Jul 28, 2020 |
| Priority date | — |
| Expiry date | Sep 21, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/53
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the identification of gene products that are the result of tumor-associated expression and the nucleic acids encoding the same. The invention also relates to the therapy and diagnosis of diseases wherein these gene products are the result of an aberrant tumor-associated expression. The invention also relates to the proteins, polypeptides and peptides that are the result of tumor-associated expression and to the nucleic acids encoding the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.